论文部分内容阅读
达美康为磺酰脲类口服高效降血糖药物,本文就其对大鼠血小板聚集功能的影响进行了初步研究,结果表明:无论是体内还是体外实验,达美康均可显著抑制ADP诱导的大鼠血小板聚集功能,且具有明显的解聚作用。
Dameikang is a highly effective hypoglycemic agent for oral administration of sulfonylureas. The preliminary study on its effect on platelet aggregation in rats was conducted. The results showed that Dameikang can significantly inhibit ADP induction both in vivo and in vitro. Rat platelet aggregation function, and has a clear depolymerization.